Activated ADAM10 targeting antibody 1H5 suppresses NOTCH-driven glioma progenitors
Umberto Tosi, Greta Ghita, Nayanendu Saha, Alexandra Giantini-Larsen, Kenny Kwok Hei Yu, Johannes Jungverdorben, Dimitar B. Nikolov, Viviane Tabar
This study shows that the antibody 1H5 targets activated ADAM10 to suppress NOTCH-driven glioma progenitors, reducing tumor growth and improving survival in xenograft models.
bioRxiv · Oct 29, 2026 · PreprintCancer Biology